Rajkot: In a major advancement for cancer care in Gujarat, the Shree Nathalal Parekh Cancer Institute, which is associated with Rajkot Cancer Society, officially launched Project Raktjyoti, ...

At ASCO, Dr Shubham Pant discussed trial results showing Daraxonrasib improved outcomes in advanced pancreatic cancer. He ...

The $5 million investment will add infusion services, radiation equipment and a new specialist.

EDITOR’S NOTE: This story was reported in collaboration with the Global Health Reporting Center with support from the ...

Healthcare providers are increasingly adopting advanced diagnostic and treatment approaches as prostate cancer remains one of ...

Drug targets previously 'undruggable' mutated protein in most pancreatic cancer cases.

Richard Scolyer, who has died aged 59, was a surgical pathologist who, with his colleague Georgina Long, revolutionised the ...

A new drug targets RAS cancer-causing cells in the pancreas, nearly doubling survival rates in clinical trials. Here's how ...

The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major ...

Tango Therapeutics said on Monday an experimental drug combination showed strong early results in a small study of patients with advanced pancreatic cancer and that ​it plans to advance the treatment ...

New long‑term results from the RUBY clinical trial show that adding immunotherapy (dostarlimab) to chemotherapy may help some ...

“Multiple cancers are increasing in incidence globally among individuals under the age of 50,” oncologist Kimmie Ng told the ...